Swiss National Bank
PMVP icon

Swiss National Bank’s PMV Pharmaceuticals PMVP Stock Holding History

Swiss National Bank’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-44,400
Closed -$212K – 2644
2023
Q1 		$212K Sell
44,400
-3,800
-8% -$26.7K ﹤0.01% 2633
2022
Q4 		$419K Hold
48,200
– – ﹤0.01% 2602
2022
Q3 		$574K Hold
48,200
– – ﹤0.01% 2522
2022
Q2 		$687K Buy
48,200
+21,400
+80% +$311K ﹤0.01% 2528
2022
Q1 		$558K Buy
26,800
+2,100
+9% +$37K ﹤0.01% 2581
2021
Q4 		$571K Hold
24,700
– – ﹤0.01% 2641
2021
Q3 		$736K Hold
24,700
– – ﹤0.01% 2510
2021
Q2 		$844K Buy
+24,700
New +$825K ﹤0.01% 2536

Other funds holding PMVP

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Swiss National Bank's PMVP Position: Q2 2023 in Review

Swiss National Bank sold out of PMV Pharmaceuticals (PMVP) in Q2 2023, closing a stake of 44,400 shares — an estimated $212K sold.

Swiss National Bank first reported a position in PMVP in Q2 2021 and held it in 8 quarters. The position peaked at $844K in Q2 2021. 106 funds tracked by Wall St. Rank hold PMVP as of Q2 2023.

  • Swiss National Bank reported no remaining PMV Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Swiss National Bank sold 44,400 PMV Pharmaceuticals shares in Q2 2023, an estimated $212K.
  • Swiss National Bank first reported a position in PMV Pharmaceuticals in Q2 2021 and held it in 8 quarters.
  • Swiss National Bank's PMV Pharmaceuticals position peaked at $844K in Q2 2021.
  • 106 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q2 2023.

Based on Swiss National Bank's 13F filing for Q2 2023, filed 9 Aug 2023.